SCHEMBL28111646

SCHEMBL28111646

CC(C)c1ccc(C(=O)c2ccc(C(C)C)c(F)c2)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B14 Q9BPX1 1/20 0.42
HDAC6 Q9UBN7 2/20 0.42
ACE2 Q9BYF1 2/20 0.41
CHRNA1 P02708 1/20 0.40
CHRNG P07510 1/20 0.40
CHRNB1 P11230 1/20 0.40
CHRNB2 P17787 1/20 0.40
SLC6A2 P23975 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627846 0.86 ACE2 (0.56) CES2CES1CYP1A2TSHRHDAC6
SCHEMBL24685741 0.86 CES2 (0.45) CES2CES1HDAC6ACE2CHRNA1
SCHEMBL4734628 0.85 PARP1 (0.44) CES2CES1HDAC6ACE2CHRNA1
SCHEMBL12263286 0.82 CA1 (0.49) CYP1A2CYP3A4CYP2C9CYP2C19LMNA
SCHEMBL16803973 0.82 HDAC6 (0.47) CES2CES1TSHRHDAC6HTT
SCHEMBL19766510 0.82 HSP90AA1 (0.43) CES2CES1HDAC6ACE2CHRNA1
SCHEMBL16958793 0.82 CES2 (0.39) CES2CES1GABRA1GABRB1CYP1A2
SCHEMBL15315482 0.81 GABRA1 (0.53) GABRA1GABRB1CYP1A2CYP3A4CYP2C9
SCHEMBL24370743 0.80 CES2 (0.40) CES2CES1CYP1A2CYP3A4CYP2C9
SCHEMBL8075446 0.79 GABRA1 (0.61) CES2CES1GABRA1GABRB1HSD17B14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103517910-B Morpholine-spirocyclic piperidine amides as modulators of ion channels 沃泰克斯药物股份有限公司 2016-12-14 CN disclosed